Tag: neurodegenerative disorders

NE3107 Drug Therapy
TechCare Scope

BioVie’s NE3107 Demonstrates Potential Improvements in Motor and Non-motor Symptoms for Parkinson’s Disease Patients and May Be Realigning Physiological Processes for Alzheimer’s Patients in Data to be Presented at the International Conference on Alzheimer’s and Parkinson’s Diseases 2024

Mar 2, 2024 0 Comments

BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today announced two upcoming…

Alpha-synuclein Pathology Detection in Alzheimer's Disease
Uncategorized

New Paper Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, Demonstrates Correlation Between the Presence of Misfolded α-Synuclein and Clinical Presentations of Alzheimer’s Disease

Feb 10, 2024 0 Comments

Amprion is pleased to be affiliated with a new scientific paper published in Alzheimer’s & Dementia, entitled “Investigating alpha-synuclein co-pathology in Alzheimer’s disease by means of cerebrospinal fluid alpha-synuclein seed amplification…

You missed

Pharmaceuticals

Rusan Pharma’s API Plant in Ankleshwar (India)Receives USFDA GMP Approval

Jul 26, 2024 0 Comments
Pharmaceuticals

SOL LABS Introduces Two New Innovative Sun Protection Solutions

Jul 25, 2024 0 Comments
TechCare Scope

Beckman Coulter’s DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.’s Annual Supplier Innovation Celebration

Jul 25, 2024 0 Comments
TechCare Scope

Aspen Laser Launches New Ascent Laser Series

Jul 25, 2024 0 Comments